Effects of Clinicopathological Characteristics on the Survival of Patients Treated with PD-1/PD-L1 Inhibitor Monotherapy or Combination Therapy for Advanced Cancer: A Systemic Review and Meta-Analysis

Figure 2

Subgroup analysis for monotherapy. HR: hazard ratio; Y: yes; N: no.